Deficiency in CD36 has been shown to be reduce proinflammatory signaling, cell recruitment, Ccl2 and Vcam1 levels in models of ischemic stroke and atherosclerosis [66, 68, 69]. This evidence concerns the gene VCAM1 and ischemic stroke.